Benefit of Single Port-surgery in Sleeve Gastrectomy

NCT ID: NCT02360176

Last Updated: 2020-09-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

332 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-04

Study Completion Date

2022-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Demonstrate non-inferiority of the single port for sleeve gastrectomy compared to the reference method in terms of complications using a score of morbidity and mortality at 6 and 24 months: Rate of fistula, intra and extra abdominal abcess, hemorrhage, gastric stenosis, splenic lesions, hernia, residual gastric pouch and mortality

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The single port surgery is the natural evolution of laparoscopy. To date only few studies have evaluated the feasibility of this technique in sleeve gastrectomy. The investigators want to demonstrate the non-inferiority in terms of morbidity-mortality of use single trocar in sleeve gastrectomy compared the multiport technique. Moreover it should highlight the non-inferiority in terms of anatomical quality, reduction of excess weight lost, reduction of comorbidities, decrease post operative pain, improved quality of life and evaluate medico-economic impact of these technique to validating this new surgical approach for bariatric surgery. The study will be multicentric with 6 university center (Montpellier, Amiens, Lille, Creteil, Poissy and Montsouris Institut). 388 patients will be included in the tow group of the prospective randomise study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgical Treatment of Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sleeve gastrectomy single port

Sleeve gastrectomy single port

Group Type EXPERIMENTAL

Sleeve gastrectomy single port

Intervention Type PROCEDURE

Bariatric surgery: one incision of 2.5 to 3 cm

Sleeve gastrectomy multi trocar

Sleeve gastrectomy multi trocar

Group Type ACTIVE_COMPARATOR

Sleeve gastrectomy multi trocar

Intervention Type PROCEDURE

Bariatric surgery: 4 to 7 incisions of 1 to 2 cm

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sleeve gastrectomy single port

Bariatric surgery: one incision of 2.5 to 3 cm

Intervention Type PROCEDURE

Sleeve gastrectomy multi trocar

Bariatric surgery: 4 to 7 incisions of 1 to 2 cm

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI\> 35 kg/m2 with comorbidity (s) or\> 40 kg/m2
* Patients aged 18 to 65 years
* Discussion and decision sleeve gastrectomy multidisciplinary meeting
* Free, informed and written consent
* Affiliation to a social security or other assurance

Exclusion Criteria

* Uncontrolled severe infection
* Liver disease other than obesity pathology
* Pregnancy (positive hCG)
* Large hiatal hernia
* Esophagitis uncontrolled
* History of gastric bypass and gastric surgery other than gastric banding
* Saving Justice guardianship
* Participation in another ongoing study
* Cognitive or severe mental illness
* Severe and non-stabilized eating disorders
* Addiction to alcohol and psychoactive substances"
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guillaume Pourcher, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Montsouris Institut

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Montsouris Insitut

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P130940

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Endoscopic Sleeve Gastroplasty
NCT02948621 COMPLETED